Elefant CMS 1.3.12-RC Version Comparison Persistent cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.8 | $0-$5k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in Elefant CMS 1.3.12-RC. This issue affects some unknown processing of the component Version Comparison. This manipulation causes cross site scripting (Persistent). This vulnerability is registered as CVE-2017-20058. Remote exploitation of the attack is possible. No exploit is available. It is suggested to upgrade the affected component.
Details
A vulnerability classified as problematic was found in Elefant CMS 1.3.12-RC (Content Management System). Affected by this vulnerability is an unknown code of the component Version Comparison. The manipulation with an unknown input leads to a cross site scripting vulnerability (Persistent). The CWE definition for the vulnerability is CWE-80. The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes special characters such as "<", ">", and "&" that could be interpreted as web-scripting elements when they are sent to a downstream component that processes web pages. As an impact it is known to affect integrity.
The weakness was published 02/16/2017 by Tim Coen with Curesec Research Team as Elefant CMS 1.3.12-RC: Multiple Persistent and Reflected XSS as not defined mailinglist post (Full-Disclosure). It is possible to read the advisory at seclists.org. This vulnerability is known as CVE-2017-20058. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. It demands that the victim is doing some kind of user interaction. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
The vulnerability was handled as a non-public zero-day exploit for at least 283 days. During that time the estimated underground price was around $0-$5k.
Upgrading to version 1.3.13 eliminates this vulnerability.
Similar entries are available at VDB-97254, VDB-97256, VDB-97257 and VDB-97258. Be aware that VulDB is the high quality source for vulnerability data.
Product
Type
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.8
VulDB Base Score: 4.3
VulDB Temp Score: 3.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Researcher Base Score: 🔍
Exploiting
Name: PersistentClass: Cross site scripting / Persistent
CWE: CWE-80 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: CMS 1.3.13
Timeline
05/09/2016 🔍02/16/2017 🔍
02/24/2017 🔍
06/18/2022 🔍
Sources
Advisory: Elefant CMS 1.3.12-RC: Multiple Persistent and Reflected XSSResearcher: Tim Coen
Organization: Curesec Research Team
Status: Not defined
CVE: CVE-2017-20058 (🔍)
GCVE (CVE): GCVE-0-2017-20058
GCVE (VulDB): GCVE-100-97255
See also: 🔍
Entry
Created: 02/24/2017 15:42Updated: 06/18/2022 16:18
Changes: 02/24/2017 15:42 (51), 08/17/2020 09:26 (2), 06/18/2022 16:18 (3)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.